Deflazacort is a glucocorticoid used as an anti-inflammatory and immunosuppressant. It was patented in 1965 and approved for medical use in 1985. The U.S. Food and Drug Administration considers it to be a first-in-class medication for Duchenne muscular dystrophy.
Specification
Brand Name |
Nr |
Manufacturer |
Standard |
Packaging Size |
Drum |
Packaging Type |
Drum |
Product Type |
Api |
Form |
Powder |
Grade Standard |
Standard |
Purity |
99 |